Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 653

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1B
Chunk 653
---
or promoting or maintaining a market for the Company’s securities) of the Company or its subsidiaries. As of March 28, 2025,
there were 2,139,240 shares available for issuance under the 2023 Plan.

Recent
Sales of Unregistered Securities 

    Name
     
    Date
     
    Type
     
    Type
    of Award

    Quantity

    Price
  
    A
    consultant
     
    January
    24, 2024
     
    Granted
     
    Non-qualified
    Stock Option; Common Stock

    180,000

    $
    1.33
  
    Dana
    Eschenburg Perez, our former Chief Financial Officer
     
    March
    15, 2024
     
    Granted
     
    Non-qualified
    Stock Option; Restricted Stock

    7,500

    $
    1.33
  
    Dana
    Eschenburg Perez, our former Chief Financial Officer
     
    March
    15, 2024
     
    Granted
     
    Non-qualified
    Stock Option; Common Stock

    49,605

    $
    1.33
  
    A
    consultant
     
    April
    17, 2024
     
    Granted
     
    Non-qualified
    Stock Option; Common Stock

    67,500

    $
    1.33

The
above issuances/sales were made pursuant to an exemption from registration as set forth in Section 4(a)(2) of the Securities Act and/or
Rule 506 of Regulation D promulgated under the Securities Act.

82

Purchases
of Equity Securities by the Issuer and Affiliated Purchasers

None. 

Transfer
Agent

The
Company’s transfer agent is Equiniti Trust Company. The transfer agent’s address is 1110 Centre Pointe Curve, Suite 101,
Mendota Heights, Minnesota 55120, and its telephone number is (800) 401-1957.

ITEM
6. [RESERVED]

ITEM
7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Special
Note Regarding Forward-Looking Statements

All
statements other than statements of historical fact included in this Annual Report on Form 10-K, including, without limitation, statements
under “Management’s Discussion